专利检索 ap:("Cook Biotech, Inc." OR "MED INSTITUTE, INC." OR "Cook Incorporated") AND inv:"PATEL, Umesh H." 第 1 页

1.

发明授权
METHOD FOR OBTAINING A PURIFIED COLLAGEN-BASED MATRIX FROM SUBMUCOSA TISSUE 失效
标题翻译： PROCEDURE用于获得GEREIGNIGTEN基于胶原的基质从面料粘膜下层

公开(公告)号：EP0925077B1

公开(公告)日：2003-10-15

申请号：EP97954888.0

申请日：1997-08-22

申请人： Cook Biotech, Inc. , MED INSTITUTE, INC. , Cook Incorporated

发明人： COOK, William A. , HILES, Michael C. , KOZMA, Thomas G. , PATEL, Umesh H.

IPC分类号： A61L27/00 , A61F2/00

CPC分类号： A61L27/24 , A61F2/06 , A61F2/07 , A61L2/0088 , A61L27/3604 , A61L27/3662 , A61L27/3683 , A61L27/3695 , A61L27/3839 , A61L27/3843 , A61L27/386 , A61L29/005 , A61L31/005 , Y10S623/925

摘要： A graft prosthesis (11), materials and method for implanting, transplanting, replacing, or repairing a part of a patient. The graft prosthesis includes a purified, collagen-based matrix structure removed from a submucosa tissue source. The submucosa tissue source is purified by disinfection and removal steps to deactivate and remove contaminants, thereby making the purified structure biocompatible and suitable for grafting on and/or in a patient.

2.

发明公开
GRAFT PROSTHESIS, MATERIALS AND METHODS 失效
标题翻译：移植移植物，材料和方法

公开(公告)号：EP0925077A2

公开(公告)日：1999-06-30

申请号：EP97954888.0

申请日：1997-08-22

申请人： Cook Biotech, Inc. , MED INSTITUTE, INC. , Cook Incorporated

发明人： COOK, William A. , HILES, Michael C. , KOZMA, Thomas G. , PATEL, Umesh H.

IPC分类号： C12N5 , A61F2 , A61K35 , A61L2 , A61L27 , A61L29 , A61L31

CPC分类号： A61L27/24 , A61F2/06 , A61F2/07 , A61L2/0088 , A61L27/3604 , A61L27/3662 , A61L27/3683 , A61L27/3695 , A61L27/3839 , A61L27/3843 , A61L27/386 , A61L29/005 , A61L31/005 , Y10S623/925

摘要： A graft prosthesis (11), materials and method for implanting, transplanting, replacing, or repairing a part of a patient. The graft prosthesis includes a purified, collagen-based matrix structure removed from a submucosa tissue source. The submucosa tissue source is purified by disinfection and removal steps to deactivate and remove contaminants, thereby making the purified structure biocompatible and suitable for grafting on and/or in a patient.